Stockscreener 앱 받기
13.19
5.45%
-0.76
시간 외 거래:
13.19
전일 마감가:
$13.95
열려 있는:
$14.01
하루 거래량:
1.23M
Relative Volume:
1.25
시가총액:
$587.77M
수익:
$110.24M
순이익/손실:
$-66.44M
주가수익비율:
-8.7287
EPS:
-1.5111
순현금흐름:
$-61.12M
1주 성능:
-3.86%
1개월 성능:
+39.43%
6개월 성능:
-54.81%
1년 성능:
-27.65%
1일 변동 폭
$13.17
$14.24
1주일 범위
$13.17
$15.00
52주 변동 폭
$8.80
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
명칭
Beta Bionics Inc
전화
949-427-7785
주소
11 HUGHES, IRVINE
Compare BBNX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
13.19 | 640.80M | 110.24M | -66.44M | -61.12M | -1.5111 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-09 | 개시 | UBS | Buy |
| 2026-01-27 | 개시 | TD Cowen | Hold |
| 2026-01-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-10-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-12 | 개시 | Lake Street | Buy |
| 2025-05-30 | 개시 | Goldman | Neutral |
| 2025-05-30 | 개시 | Wolfe Research | Outperform |
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Reviews Investor Losses Following Slower New Patient Start Growth - TradingView
Beta Bionics (BBNX) Securities Investigation: Johnson - GlobeNewswire
Beta Bionics (BBNX) Securities Investigation: Johnson Fistel Rev - GuruFocus
Insider Sell: Mark Hopman Sells Shares of Beta Bionics Inc (BBNX) - GuruFocus
Beta bionics CCO Mark Hopman sells $3,385 in shares By Investing.com - Investing.com South Africa
Beta bionics CCO Mark Hopman sells $3,385 in shares - Investing.com UK
Beta Bionics | 4: Statement of changes in beneficial ownership of securities-Officer Hopman Mark - Moomoo
Beta Bionics | 4: Statement of changes in beneficial ownership of securities-Director Jones Christy - Moomoo
Beta bionics director Jones Christy sells $39,354 in stock - Investing.com UK
Beta bionics director Jones Christy sells $39,354 in stock By Investing.com - Investing.com South Africa
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information - GlobeNewswire
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information - GlobeNewswire Inc.
Beta Bionics (BBNX) CCO logs small 275-share sale under Rule 10b5-1 plan - Stock Titan
Beta Bionics (NASDAQ: BBNX) director sells 2,811 shares in planned trade - Stock Titan
Have Beta Bionics Insiders Been Selling Stock? - simplywall.st
BBNX Q1 2026 Earnings: Narrower Loss Surprises, Stock Jumps 11.57%Investor Earnings Call - newsline.com
Beta Bionics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
BBNX Investor Notice: Robbins LLP Reminds Beta Bionics, Inc. That it is Investigating The Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders - ACCESS Newswire
Christina Jones to sell 2,811 BBNX shares (NASDAQ: BBNX) under 10b5-1 - Stock Titan
BBNX (NASDAQ: BBNX) affiliate files Rule 144 to sell 275 shares - Stock Titan
Beta Bionics, Inc. (BBNX) Investigation: Johnson Fistel - GlobeNewswire
Beta bionics CPO Mike Mensinger sells $55,193 in stock By Investing.com - Investing.com India
Beta bionics CPO Mike Mensinger sells $55,193 in stock - Investing.com
Beta Bionics (BBNX) CPO sells 4,378 shares to cover RSU tax withholding - Stock Titan
Beta Bionics (NASDAQ: BBNX) CCO sells 5,329 shares to cover RSU taxes - Stock Titan
Beta Bionics (BBNX) CMO sells 4,222 shares to cover tax obligations - Stock Titan
Beta Bionics (BBNX) CFO sells 6,676 shares to cover RSU tax obligations - Stock Titan
Beta Bionics (NASDAQ: BBNX) CEO sells 16,872 shares to cover RSU taxes - Stock Titan
BBNX (NASDAQ) director/resignee plans resale of RSUs vesting 06/01/2026 - Stock Titan
BBNX (NASDAQ) Form 144: 4,222 vested RSU shares via Morgan Stanley - Stock Titan
Insider sale filing: Beta Bionics (NASDAQ: BBNX) proposes 4,378-share sale - Stock Titan
6,676 RSUs vest; BBNX (NASDAQ: BBNX) Form 144 notes prior 1,428-share sale - Stock Titan
BBNX (NASDAQ: BBNX) affiliate notifies planned sale of 16,872 shares via broker - Stock Titan
Beta Bionics, Inc. Securities Fraud Investigation – Robbins - GlobeNewswire
Beta Bionics Investors Suffer Significant Losses After Company Re - The National Law Review
Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel - Business Wire
Beta Bionics Under Investigation for Securities Violations - Intellectia AI
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, - GlobeNewswire
Beta Bionics Publishes Near Real-Time Real-World Data Dashboard for the Ilet Bionic Pancreas - marketscreener.com
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. S - GuruFocus
Beta Bionics Investors Who Suffered Losses May Be Eligible for Recovery-Learn More Today, Contact Johnson Fistel - marketscreener.com
Beta Bionics launches real-time data dashboard for iLet device - Investing.com
Beta Bionics launches real-time data dashboard for iLet device By Investing.com - Investing.com Australia
Beta Bionics First in Automated Insulin Delivery to Publish Near Real-Time Real-World Data on a Public Website - The Manila Times
See every iLet patient outcome: Beta Bionics puts real-world data online - Stock Titan
Robbins LLP is Investigating Allegations that the Officers and Directors of Beta Bionics, Inc. (BBNX) Violated Securities Laws and Breached Fiduciary Duties to Shareholders - The AI Journal
Beta Bionics Inc (BBNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Beta Bionics Inc 주식 (BBNX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Jones Christy | Director |
Jun 04 '26 |
Sale |
14.00 |
2,811 |
39,354 |
27,400 |
2.43%
자본화:
|
볼륨(24시간):